[1]
“Effect of Combination Treatment with GLP-1 Receptor Agonist and SGLT-2 Inhibitors on Incidence of Cardiovascular and Serious Renal Events ”, mfm, vol. 35, no. 6, Jun. 2024, Accessed: Nov. 17, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/4697